SlideShare a Scribd company logo
!
!
UKMenCar4:
carriage studies, high-resolution
genomics, and disease control
Martin Maiden,
UKMenCar4 Consortium
Meningococcal structure and
characterisation
Jolley, K. A., Brehony, C. & Maiden, M. C. (2007). Molecular typing of meningococci:
recommendations for target choice and nomenclature. FEMS Microbiol Rev 31, 89-96.
Component Phenotypic Genotypic
Capsule Serogroup cps region
OMPS Serotype,
Subtype, etc.
porA, porB,
fetA, etc.
Housekeeping
genes
MLEE MLST
Ribosomes MALDITOF 16s rRNA,
rMLST
Neisseria meningitidis B: P1.7,16: F3-3: ST-32 (cc32)
Meningococcal disease, England &
Wales: the long view
-
5.00
10.00
15.00
20.00
25.00
30.00
35.00
Incidencerate/100,000
Year
The Big Questions:
(i) Why was there such high
disease incidence mid-1980s –
mid-2000s?;
(ii) Why has it reduced?; and,
(iii) What is likely to happen next?
Cerebrospinal Fever Meningococcal: infection meningitis & septicaemia
Data: courtesy Mary Ramsay Shamaz Ladhani, Public Health England
Meningococcal disease epidemics
England & Wales 1984-2013
Data: Meningococcal Reference Unit, Public Health England
1982-1990
Stonehouse
Outbreak
Group B
1993-1999
Group C
Outbreaks
2001 -
Group B
Incidence
declines
Late 1999
Group C
Conjugate
Meningococcal
(MCC) Vaccines
introduced
Meningitis Research Foundation
Meningococcus Genome Library
• Charity funded.
• Open access.
• All available England
and Wales, Scotland
(and Ireland, WT
funded) meningococcal
isolates.
• Assembled &
annotated contiguous
sequence data.
http://www.meningitis.org/current-projects/genome
Diversity of disease causing meningococci
MRF-MGL isolates 2010-2012
Hill, D.M.C., Lucidarme, J., Gray S.J., Newbold , L.S., Ure, R., Brehony, C., Harrison, O.B., Bray, J.E.,
Jolley, K.A., Bratcher H.B.,, Parkhill, J., Tang, C.M., Borrow, R., and Maiden, M.C.J. Genomic
epidemiology of age-associated meningococcal lineages in national surveillance: an observational
cohort study. Lancet Infectious diseases, DOI: http://dx.doi.org/10.1016/S1473-3099(15)00267-4
• A total of 923 isolates from
England, Wales and Northern
Ireland.
• 899 from England and Wales:
• Scanned at >2000 loci;
• 2-313 alleles/locus;
• 219 STs, 22 clonal
complexes;
• 496 rSTs (ribosomal
sequence types);
• Most isolates (78%)
belonged to 6 clonal
complexes.
0
500
1000
1500
2000
2500
3000
1975 ~ 1985 ~ 1995 ~ 1999 2000 2001 ~ 2005 2006 2007 2008 2009 2010 2011 2012
41/44 269 11 32 8 213 23 167 174 22 Other UA NT
Epidemics are dominated by particular
meningococci
Hill, D.M.C., Lucidarme, J., Gray S.J., Newbold , L.S., Ure, R., Brehony, C., Harrison, O.B., Bray, J.E.,
Jolley, K.A., Bratcher H.B.,, Parkhill, J., Tang, C.M., Borrow, R., and Maiden, M.C.J. Genomic
epidemiology of age-associated meningococcal lineages in national surveillance: an observational
cohort study. Lancet Infectious diseases, DOI: http://dx.doi.org/10.1016/S1473-3099(15)00267-4
Age association of meningococcal
genotypes (MRF-MGL 2010-2012)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
<1 1-4 5-9 10-14 15-19 20-24 25-29 30-39 40-49 50-69 >70
Proportionofcases
Age category
Minor clonal complexes
ND
ST-174 complex
ST-461 complex
ST-162 complex
ST-22 complex
ST-23 complex/Cluster A3
ST-213 complex
ST-60 complex
ST-41/44 complex/Lineage 3
ST-269 complex
ST-32 complex/ET-5 complex
ST-11 complex/ET-37 complex
Hill, D.M.C., Lucidarme, J., Gray S.J., Newbold , L.S., Ure, R., Brehony, C., Harrison, O.B., Bray, J.E.,
Jolley, K.A., Bratcher H.B.,, Parkhill, J., Tang, C.M., Borrow, R., and Maiden, M.C.J. Genomic
epidemiology of age-associated meningococcal lineages in national surveillance: an observational
cohort study. Lancet Infectious diseases, DOI: http://dx.doi.org/10.1016/S1473-3099(15)00267-4
0
5
10
15
20
25
<1
1
2
3
4-6
7-9
10-12
13-15
16-18
19-21
22-24
25-27
28-30
31-33
34-36
37-39
40-43
44-46
47-49
50-52
53-55
56-58
59-61
62-64
65-67
68-70
71-73
74-76
77-79
80-82
83-85
86-88
89-91
92-94
95-97
>97
NK
ProportionofIMDCasesEpidemiologicalYear(%)
Patient Age (Years)
2010/11
2011/12
0
1
2
3
4
5
6
7
8
9
<1 1-3 4-6 7-9 10-11
ProportionofCases
EpidemiologicalYear(%)
Patient Age (Months)
Age distribution of isolates in
meningococcal genome library
Meningococcal carriage by age
Christensen, H., May, M., Bowen, L., Hickman, M. & Trotter, C. L. (2010). Meningococcal carriage by
age: a systematic review and meta-analysis. The Lancet Infectious Diseases 10, 853-861.
100 years of disease and carriage
studies
Glover, J. A. (1918). "Spacing out"
in the Prevention of Military
Epidemics of Cerebro-Spinal Fever.
Br Med J 2, 509-512.
Glover, J. A. (1918). Observations
on the Meningococcus Carrier-
Rate in relation to density of
population in Sleeping Quarters. J
Hyg (Lond) 17, 367-379.
Glover, J. A. (1918). The Cerebro-
Spinal Fever Epidemic of 1917 at X
Depot. J Hyg (Lond) 17, 350-365.
Meningococcal disease England & Wales
Data: Meningococcal Reference Unit, Public Health England
Late 1999
Group C
Conjugate
Meningococcal
(MCC) Vaccines
introduced
UK Meningococcal carriage study:
UKMenCar1-3, 1999-2001
Ibarz-Pavon, A. B., et al. (2011). Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during
vaccine implementation. J Infect Dis 204, 1046-1053.
Maiden, M. C., et al. (2008). Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity. J Infect Dis 197,
737-743.
Maiden, M. C., Stuart, J. M. & Group, U. M. C. (2002). Carriage of serogroup C meningococci 1 year after meningococcal C conjugate
polysaccharide vaccination. Lancet 359, 1829-1831.
Glasgow
Stockport
Nottingham
Oxford
London
Plymouth
Wales
MRU/SMPRL
Phenotype
16,700 X 3
Sequence type siaD/cnl
Questionnaire
Risk factors for carriage
2,500 X 3
UKMenCar 1-3: 8,000 carried meningococci, a
diverse population
0
2
4
6
8
10
12
14
16
1999 2000 2001
Proportionofmeningococci(%)
Year
ST-11 complex
ST-865 complex
ST-8 complex
ST-254 complex
ST-212 complex
ST-162 complex
ST-92 complex
ST-18 complex
ST-178 complex
ST-1136 complex
ST-750 complex
ST-41/44 complex
ST-167 complex
ST-32 complex
ST-60 complex
ST-282 complex
ST-364 complex
ST-35 complex
ST-22 complex
ST-198 complex
ST-103 complex
ST-23 complex
ST-53 complex
ST-1157 complex
ST-269 complex
ST-1117 complex
ST-213 complex
ST-461 complex
ST-174 complex
ST-106 complex
ST-116 complex
ST-334 complex
ST-37 complex
ST-376 complex
Ibarz-Pavon, A. B., Maclennan, J., Andrews, N. J., Urwin, R., Gray, S. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal,
K. R., Ala'aldeen, D. A., Crook, D. W., Cann, K., Harrison, S., Cunningham, R., Baxter, D., Kaczmarski, E., Cameron, J. C. & Stuart,
J. M., & Maiden, M. C. (In press). Changes in serogroup and genotype prevalence among carried meningococci in the United
Kingdom during vaccine implementation. J Infect Dis.
UKMenCar1-3:
major disease associated lineages
0
2
4
6
8
10
12
14
16
1999 2000 2001
Proportionofmeningococci(%)
Year
ST-11 complex ST-8 complex
ST-41/44 complex ST-32 complex
ST-269 complex
Clonal
complex
1998/9
n
1998/9
%
2000/1
n
2000/1
%
ST-11
complex
553 32.8 264 20.5
ST-41/44
complex
423 25.1 373 28.9
ST-269
complex
253 15.0 275 21.3
ST-32
complex
99 5.9 79 6.1
ST-8
complex
84 5.0 15 1.2
a) Carried meningococcal clonal complexes b) Clonal complexes isolated from disease
Maiden, M. C., Ibarz-Pavon, A. B., Urwin, R., Gray, S. J., Andrews, N. J., Clarke,
S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., Ala'aldeen, D. A.,
Crook, D. W., Cann, K., Harrison, S., Cunningham, R., Baxter, D., Kaczmarski, E.,
Maclennan, J., Cameron, J. C. & Stuart, J. M. (2008). Impact of Meningococcal
Serogroup C Conjugate Vaccines on Carriage and Herd Immunity. J Infect Dis
197, 737-743.
UKMenCar 1-3: Carriage of ST-11
genogroup C isolates
0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
1999 2000 2001
%Carriage
Year
NG
C
Maiden, M. C., et al. (2008). Impact of Meningococcal Serogroup C Conjugate Vaccines
on Carriage and Herd Immunity. J Infect Dis 197, 737-743.
Clonal complex, disease, and serogroup
England and Wales, 1999
Clonal complex Disease association OR B C W-135 Y
ST-8 14.7 [6.8 - 31.9] 11 69 0 0
ST-11 28.7 [20.1 - 41.1] 7 525 1 0
ST-22 0.23 [0.17 - 0.32] 5 0 42 1
ST-23 0.14 [0.07 - 0.28] 0 1 0 9
ST-32 2.1 [1.5 - 3.0] 80 1 0 0
ST-35 0.29 [0.16 - 0.53] 13 0 0 0
ST-41/44 1.8 [1.5 - 2.1] 390 7 0 0
ST-213 0.4 [0.28 - 0.57] 39 1 0 0
ST-269 4.4 [3.4 - 5.8] 214 7 0 0
Unassigned 0.28 [0.24 - 0.34] 140 32 2 9
Data: Ure R., Gray S., McCarthy N.D., Pavon A.B., and Maiden, M.C. Unpublished.
Risk factors for carriage
Smoking Kissing
Y Y
Y N
N Y
N N
MacLennan, J., Kafatos, G., Neal, K., Andrews, N., Cameron, J. C., Roberts, R., Evans, M.
R., Cann, K., Baxter, D. N., Maiden, M. C. & Stuart, J. M. (2006). Social behavior and
meningococcal carriage in British teenagers. Emerg Infect Dis 12, 950-957.
The long-term impact of herd
immunity
Trotter, C. L. & Maiden, M. C. (2009). Meningococcal vaccines and herd immunity: lessons
learned from serogroup C conjugate vaccination programs. Expert Review Vaccines 8, 851-861.
Meningococcal disease England & Wales
Data: Meningococcal Reference Unit, Public Health England
1982-1990
Stonehouse
Outbreak
Group B
1993-1999
Group C
Outbreaks
2001 -
Group B
Incidence
Declines
Late 1999
Group C
Conjugate
Meningococcal
(MCC) Vaccine
introduced
UKMenCar4: Initial aims
1) Compare the genotypes of
meningococcal disease and
carriage isolates in high and low
incidence settings (UK 1999 and
UK 2014).
2) Investigate the risk factors for
meningococcal carriage and in
particular the effect of changes in
social behaviour with respect to
smoking, kissing, and socialising.
Incidence Carriage Disease
High (1999) ✔ ✔
Low (2014) ✔ ✔
UK Meningococcal carriage study,
UKMenCar4: 2014-5
Glasgow
Stockport
Manchester
Oxford
London
Plymouth
Cardiff
MaidstoneBristol
Wigan
Preston
• Multi-centre cross-sectional survey
of meningococcal carriage
• 18,000 UK teenagers
• Compared to UKmenCAR1-3:
– Similar study sites;
– Same age group;
– Sampling in schools/colleges;
– Similar time of year (but
extended from autumn to
spring);
– Similar microbiological
methods;
– Same key risk factors.
Sampling
Tributyrin Test
* Positive reaction: yellow/yellow orange
* Negative reaction: red
Results: Moraxella catarrhalis (+)
Neisseria spp. (-)
Microbiology testing
Genome sequencing of Neisseria
meningitidis isolates
|||||||||||
OX40001 |||||||||||
OX40001
|||||||||||
OX40001
Sequence read
processing
Visualization
Analysis of study data
These are just some of the
types of analyses possible …
Cluster 1
Cluster 2
Cluster 3
Genome analysis of disease and
carriage isolates from Chad
 Reference genome: 2070 genes from ST5
WUE2594 [Schoen, C. et al., 2011]
 Genome comparator output:
 1542 genes identical in all genomes (1347
share same allele as ref/196 have a different
allele);
 66 genes missing in all 23 genomes;
 221 incomplete genes were excluded;
 242 variable genes.
Diallo K, Trotter C, Borrow R, Stuart JM, Greenwood BM, Maiden MCJ, &
MenAfriCar consortium. Unpublished.
UKMenCar4 totals by centre
Centre Recruitment
target
Final total
Glasgow 2600 2632
Bristol 2600 1814
London 2600 1933
Oxford 2600 2141
Stockport 2600 2438
Cardiff 2600 3130
Plymouth 1500 2252
Maidstone 1000 1022
Preston 1000 1016
Central Manchester
& Wigan
1000 3497
Total 20,100 21,874
UKMenCar4: Meningococcal carriage rates
1999-2000 2000-2001 2001-2002 2014-2015
Carriage of Neisseria meningitidis * Putative
meningococci
Stockport 25.4 % 24.9 % 24.4 % 11.7 %
Cardiff 14.4 % 17.6 % 16.7 % 8.6 %
Glasgow 11.7 % 16.2 % 17.5 % 7.1 %
Oxford 25.2 % 22.6 % 20.3 % 9.3 %
Plymouth 8.2 % 15.4 % 19.9 % 5.9 %
Bristol N/A N/A N/A 8.4 %
North Thames 9.1 % 12.5 % 14.4 % N/A
Bangor 20.9 % 19.2 % 22.9 % N/A
Nottingham 19.9 % 19.8 % 16.0 % N/A
Shisha smokingSmoking ban 2006/7
Changes since UKMencar1-3: smoking
Meningococcal disease England & Wales
Data: Meningococcal Reference Unit, Public Health England
1982-1990
Stonehouse
Outbreak
Group B
1993-1999
Group C
Outbreaks
2001 -
Group B
Incidence
declines
Late 1999
Group C
Conjugate
Meningococcal
(MCC) Vaccine
introduced
What
Next?
MRF Genome Library Era:
England and Wales 2010-2015
0
50
100
150
200
250
300
350
400
450
B
C
W
Y
http://www.meningitis.org/current-projects/genome
Lineage 11 (cc11) Group W: UK
epidemiology
Current UK
UK Hajj
UK
1996 (n=3)
1997 (n=2)
1998 (n=2)
UK
1975 (n=6)
1987 (n=1)
1989 (n=1)
1990 (n=1)
UK
1996 (n=2)
1998 (n=1)
Argentina 2008-2012
Brazil 2008-2011
Current South Africa
Lucidarme, J., Hill, D. M., Bratcher, H. B., Gray, S. J., du Plessis, M., Tsang, R. S., Vazquez, J. A., Taha, M. K., Ceyhan,
M., Efron, A. M., Gorla, M. C., Findlow, J., Jolley, K. A., Maiden, M. C. & Borrow, R. (2015). Genomic resolution of an
aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage. J Infect In the press.
0
10
20
30
40
50
60
70
80
90
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012
NumberofCases
Year
N. meningitidis cases per year among inpatients in Bamako, Mali
(2002-2012)
Group A
meningococcal
cases
Group W135
meningococcal
cases
Nm W England and Wales
2015 vaccine introductions
UKMenCar5: Evaluation of changes in the UK national
meningococcal immunisation programme
UKMenCar4 provides the pre-vaccination baseline for
circulating meningococci and will allow full evaluation
of the impact of ACWY vaccine on meningococcal
populations.
2014 2015 2016 2017 2018
UKMenCar4 ACWY vaccination UKMenCar5
with catch up
UKMenCar4 Team

More Related Content

What's hot

Antimicrobial Susceptibility Profile of Escherichia Coli Isolates from Urine ...
Antimicrobial Susceptibility Profile of Escherichia Coli Isolates from Urine ...Antimicrobial Susceptibility Profile of Escherichia Coli Isolates from Urine ...
Antimicrobial Susceptibility Profile of Escherichia Coli Isolates from Urine ...
ijtsrd
 
Characterization of Mycobacterium Tuberculosis Complex Strains: A Multicenter...
Characterization of Mycobacterium Tuberculosis Complex Strains: A Multicenter...Characterization of Mycobacterium Tuberculosis Complex Strains: A Multicenter...
Characterization of Mycobacterium Tuberculosis Complex Strains: A Multicenter...
CrimsonpublishersCJMI
 
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
Dr. Aisha M Elbareg
 
Moderna mRNA Vaccines: from Concept to Clinic
Moderna mRNA Vaccines: from Concept to ClinicModerna mRNA Vaccines: from Concept to Clinic
Moderna mRNA Vaccines: from Concept to Clinic
ModernaTherapeutics1
 
Advances in immunotherapy for lymphomas and myelomas
Advances in immunotherapy for lymphomas and myelomasAdvances in immunotherapy for lymphomas and myelomas
Advances in immunotherapy for lymphomas and myelomasspa718
 
Comparative antimicrobial activity of aspirin, paracetamol, flunixin meglumin...
Comparative antimicrobial activity of aspirin, paracetamol, flunixin meglumin...Comparative antimicrobial activity of aspirin, paracetamol, flunixin meglumin...
Comparative antimicrobial activity of aspirin, paracetamol, flunixin meglumin...
Bhoj Raj Singh
 
Monitoring efficacy gene expression frontiers
Monitoring efficacy gene expression frontiersMonitoring efficacy gene expression frontiers
Monitoring efficacy gene expression frontiers
Eliyahu Schuman
 
2016.03.08 immem talk salmonella outbreaks
2016.03.08 immem talk   salmonella outbreaks2016.03.08 immem talk   salmonella outbreaks
2016.03.08 immem talk salmonella outbreaks
Philip Ashton
 
Disease frequency of selected bacterial zoonoses in small ruminants in Tana R...
Disease frequency of selected bacterial zoonoses in small ruminants in Tana R...Disease frequency of selected bacterial zoonoses in small ruminants in Tana R...
Disease frequency of selected bacterial zoonoses in small ruminants in Tana R...
ILRI
 
2016.11.08 doherty institute symposium
2016.11.08 doherty institute symposium2016.11.08 doherty institute symposium
2016.11.08 doherty institute symposium
Philip Ashton
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacyiosrphr_editor
 
Sero-evidence of zoonotic viruses in rodents and humans in Kibera informal se...
Sero-evidence of zoonotic viruses in rodents and humans in Kibera informal se...Sero-evidence of zoonotic viruses in rodents and humans in Kibera informal se...
Sero-evidence of zoonotic viruses in rodents and humans in Kibera informal se...
ILRI
 
Role of virus in periodontal diseases
Role of virus in periodontal diseasesRole of virus in periodontal diseases
Role of virus in periodontal diseases
Dr. sneha chavan
 
Directly acting antivirals and Visceral Leishmaniasis: A case report
Directly acting antivirals and Visceral Leishmaniasis: A case reportDirectly acting antivirals and Visceral Leishmaniasis: A case report
Directly acting antivirals and Visceral Leishmaniasis: A case report
RxVichuZ
 
Whole genome sequencing as a starting point to understanding antimicrobial re...
Whole genome sequencing as a starting point to understanding antimicrobial re...Whole genome sequencing as a starting point to understanding antimicrobial re...
Whole genome sequencing as a starting point to understanding antimicrobial re...
Jennifer Gardy
 
Androgen-deprivation therapies for prostate cancer and risk of infection by S...
Androgen-deprivation therapies for prostate cancer and risk of infection by S...Androgen-deprivation therapies for prostate cancer and risk of infection by S...
Androgen-deprivation therapies for prostate cancer and risk of infection by S...
Valentina Corona
 
Ebola virus disease in the democratic republic of Congo{
Ebola virus disease in the democratic republic of Congo{Ebola virus disease in the democratic republic of Congo{
Ebola virus disease in the democratic republic of Congo{
Momina mehmood
 
Hcbcm 20-004 regeneration abilities of vertebrates and invertebrates and rela...
Hcbcm 20-004 regeneration abilities of vertebrates and invertebrates and rela...Hcbcm 20-004 regeneration abilities of vertebrates and invertebrates and rela...
Hcbcm 20-004 regeneration abilities of vertebrates and invertebrates and rela...
M. Luisetto Pharm.D.Spec. Pharmacology
 
Cervical cancer prevention current scenario
Cervical cancer prevention  current scenarioCervical cancer prevention  current scenario
Cervical cancer prevention current scenario
Nilesh Kucha
 
Evaluating the impact of a new MenB vaccine and use of MRF genome library
Evaluating the impact of a new MenB vaccine and use of MRF genome libraryEvaluating the impact of a new MenB vaccine and use of MRF genome library
Evaluating the impact of a new MenB vaccine and use of MRF genome library
Meningitis Research Foundation
 

What's hot (20)

Antimicrobial Susceptibility Profile of Escherichia Coli Isolates from Urine ...
Antimicrobial Susceptibility Profile of Escherichia Coli Isolates from Urine ...Antimicrobial Susceptibility Profile of Escherichia Coli Isolates from Urine ...
Antimicrobial Susceptibility Profile of Escherichia Coli Isolates from Urine ...
 
Characterization of Mycobacterium Tuberculosis Complex Strains: A Multicenter...
Characterization of Mycobacterium Tuberculosis Complex Strains: A Multicenter...Characterization of Mycobacterium Tuberculosis Complex Strains: A Multicenter...
Characterization of Mycobacterium Tuberculosis Complex Strains: A Multicenter...
 
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
IBacterial Pathogens Causing Urinary Tract Infections and Their Antimicrobial...
 
Moderna mRNA Vaccines: from Concept to Clinic
Moderna mRNA Vaccines: from Concept to ClinicModerna mRNA Vaccines: from Concept to Clinic
Moderna mRNA Vaccines: from Concept to Clinic
 
Advances in immunotherapy for lymphomas and myelomas
Advances in immunotherapy for lymphomas and myelomasAdvances in immunotherapy for lymphomas and myelomas
Advances in immunotherapy for lymphomas and myelomas
 
Comparative antimicrobial activity of aspirin, paracetamol, flunixin meglumin...
Comparative antimicrobial activity of aspirin, paracetamol, flunixin meglumin...Comparative antimicrobial activity of aspirin, paracetamol, flunixin meglumin...
Comparative antimicrobial activity of aspirin, paracetamol, flunixin meglumin...
 
Monitoring efficacy gene expression frontiers
Monitoring efficacy gene expression frontiersMonitoring efficacy gene expression frontiers
Monitoring efficacy gene expression frontiers
 
2016.03.08 immem talk salmonella outbreaks
2016.03.08 immem talk   salmonella outbreaks2016.03.08 immem talk   salmonella outbreaks
2016.03.08 immem talk salmonella outbreaks
 
Disease frequency of selected bacterial zoonoses in small ruminants in Tana R...
Disease frequency of selected bacterial zoonoses in small ruminants in Tana R...Disease frequency of selected bacterial zoonoses in small ruminants in Tana R...
Disease frequency of selected bacterial zoonoses in small ruminants in Tana R...
 
2016.11.08 doherty institute symposium
2016.11.08 doherty institute symposium2016.11.08 doherty institute symposium
2016.11.08 doherty institute symposium
 
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of PharmacyIOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
IOSRPHR(www.iosrphr.org) IOSR Journal of Pharmacy
 
Sero-evidence of zoonotic viruses in rodents and humans in Kibera informal se...
Sero-evidence of zoonotic viruses in rodents and humans in Kibera informal se...Sero-evidence of zoonotic viruses in rodents and humans in Kibera informal se...
Sero-evidence of zoonotic viruses in rodents and humans in Kibera informal se...
 
Role of virus in periodontal diseases
Role of virus in periodontal diseasesRole of virus in periodontal diseases
Role of virus in periodontal diseases
 
Directly acting antivirals and Visceral Leishmaniasis: A case report
Directly acting antivirals and Visceral Leishmaniasis: A case reportDirectly acting antivirals and Visceral Leishmaniasis: A case report
Directly acting antivirals and Visceral Leishmaniasis: A case report
 
Whole genome sequencing as a starting point to understanding antimicrobial re...
Whole genome sequencing as a starting point to understanding antimicrobial re...Whole genome sequencing as a starting point to understanding antimicrobial re...
Whole genome sequencing as a starting point to understanding antimicrobial re...
 
Androgen-deprivation therapies for prostate cancer and risk of infection by S...
Androgen-deprivation therapies for prostate cancer and risk of infection by S...Androgen-deprivation therapies for prostate cancer and risk of infection by S...
Androgen-deprivation therapies for prostate cancer and risk of infection by S...
 
Ebola virus disease in the democratic republic of Congo{
Ebola virus disease in the democratic republic of Congo{Ebola virus disease in the democratic republic of Congo{
Ebola virus disease in the democratic republic of Congo{
 
Hcbcm 20-004 regeneration abilities of vertebrates and invertebrates and rela...
Hcbcm 20-004 regeneration abilities of vertebrates and invertebrates and rela...Hcbcm 20-004 regeneration abilities of vertebrates and invertebrates and rela...
Hcbcm 20-004 regeneration abilities of vertebrates and invertebrates and rela...
 
Cervical cancer prevention current scenario
Cervical cancer prevention  current scenarioCervical cancer prevention  current scenario
Cervical cancer prevention current scenario
 
Evaluating the impact of a new MenB vaccine and use of MRF genome library
Evaluating the impact of a new MenB vaccine and use of MRF genome libraryEvaluating the impact of a new MenB vaccine and use of MRF genome library
Evaluating the impact of a new MenB vaccine and use of MRF genome library
 

Viewers also liked

Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Meningitis Research Foundation
 
Prof Sir Brian Greenwood @ MRF's Meningitis & Septicaemia in Children & Adult...
Prof Sir Brian Greenwood @ MRF's Meningitis & Septicaemia in Children & Adult...Prof Sir Brian Greenwood @ MRF's Meningitis & Septicaemia in Children & Adult...
Prof Sir Brian Greenwood @ MRF's Meningitis & Septicaemia in Children & Adult...
Meningitis Research Foundation
 
Dr Fiona McGill @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Fiona McGill @ MRF's Meningitis & Septicaemia in Children & Adults 2015Dr Fiona McGill @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Fiona McGill @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Meningitis Research Foundation
 
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
Meningitis Research Foundation
 
Robery Heyderman @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Robery Heyderman @ MRF's Meningitis & Septicaemia in Children & Adults 2015 Robery Heyderman @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Robery Heyderman @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Meningitis Research Foundation
 
Dr Nicole Basta @ @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Nicole Basta @ @ MRF's Meningitis & Septicaemia in Children & Adults 2015 Dr Nicole Basta @ @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Nicole Basta @ @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Meningitis Research Foundation
 
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Meningitis Research Foundation
 
Dr Mary Ramsay @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Mary Ramsay @ MRF's Meningitis & Septicaemia in Children & Adults 2015Dr Mary Ramsay @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Mary Ramsay @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Meningitis Research Foundation
 
Professor Xavier Nassif @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Xavier Nassif @ MRF's Meningitis & Septicaemia in Children & Adults...Professor Xavier Nassif @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Xavier Nassif @ MRF's Meningitis & Septicaemia in Children & Adults...
Meningitis Research Foundation
 
Marie Pierre @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Marie Pierre @ MRF's Meningitis & Septicaemia in Children & Adults 2015 Marie Pierre @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Marie Pierre @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Meningitis Research Foundation
 
Dr Olivier Ronveaux @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Olivier Ronveaux @ MRF's Meningitis & Septicaemia in Children & Adults 2015Dr Olivier Ronveaux @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Olivier Ronveaux @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Meningitis Research Foundation
 
The meaning of meningococcal carriage - Slideset by Professor Adam Finn
The meaning of meningococcal carriage - Slideset by Professor Adam FinnThe meaning of meningococcal carriage - Slideset by Professor Adam Finn
The meaning of meningococcal carriage - Slideset by Professor Adam Finn
WAidid
 
Debate on aggressive vs restricted fluid resuscitation in childhood sepsis
Debate on aggressive vs restricted fluid resuscitation in childhood sepsisDebate on aggressive vs restricted fluid resuscitation in childhood sepsis
Debate on aggressive vs restricted fluid resuscitation in childhood sepsis
Meningitis Research Foundation
 
Round up of new developments in clinical management of meningitis or sepsis i...
Round up of new developments in clinical management of meningitis or sepsis i...Round up of new developments in clinical management of meningitis or sepsis i...
Round up of new developments in clinical management of meningitis or sepsis i...
Meningitis Research Foundation
 
Neonatal meningitis in the UK
Neonatal meningitis in the UKNeonatal meningitis in the UK
Neonatal meningitis in the UK
Meningitis Research Foundation
 
Moraxella
MoraxellaMoraxella
Moraxella
Donna Potter
 
Salmonella infections
Salmonella infectionsSalmonella infections
Salmonella infectionsJasmine John
 
Salmonellosis
Salmonellosis Salmonellosis
Salmonellosis
Dr.Bharat Kalidindi
 

Viewers also liked (20)

Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Marco Safadi @ MRF's Meningitis & Septicaemia in Children & Adults 2015
 
Prof Sir Brian Greenwood @ MRF's Meningitis & Septicaemia in Children & Adult...
Prof Sir Brian Greenwood @ MRF's Meningitis & Septicaemia in Children & Adult...Prof Sir Brian Greenwood @ MRF's Meningitis & Septicaemia in Children & Adult...
Prof Sir Brian Greenwood @ MRF's Meningitis & Septicaemia in Children & Adult...
 
Dr Fiona McGill @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Fiona McGill @ MRF's Meningitis & Septicaemia in Children & Adults 2015Dr Fiona McGill @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Fiona McGill @ MRF's Meningitis & Septicaemia in Children & Adults 2015
 
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Richard Beale @ MRF's Meningitis & Septicaemia in Children & Adults...
 
Robery Heyderman @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Robery Heyderman @ MRF's Meningitis & Septicaemia in Children & Adults 2015 Robery Heyderman @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Robery Heyderman @ MRF's Meningitis & Septicaemia in Children & Adults 2015
 
Dr Nicole Basta @ @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Nicole Basta @ @ MRF's Meningitis & Septicaemia in Children & Adults 2015 Dr Nicole Basta @ @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Nicole Basta @ @ MRF's Meningitis & Septicaemia in Children & Adults 2015
 
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Professor Ray Borrow @ MRF's Meningitis & Septicaemia in Children & Adults 2015
 
Dr Mary Ramsay @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Mary Ramsay @ MRF's Meningitis & Septicaemia in Children & Adults 2015Dr Mary Ramsay @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Mary Ramsay @ MRF's Meningitis & Septicaemia in Children & Adults 2015
 
Professor Xavier Nassif @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Xavier Nassif @ MRF's Meningitis & Septicaemia in Children & Adults...Professor Xavier Nassif @ MRF's Meningitis & Septicaemia in Children & Adults...
Professor Xavier Nassif @ MRF's Meningitis & Septicaemia in Children & Adults...
 
Marie Pierre @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Marie Pierre @ MRF's Meningitis & Septicaemia in Children & Adults 2015 Marie Pierre @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Marie Pierre @ MRF's Meningitis & Septicaemia in Children & Adults 2015
 
Dr Olivier Ronveaux @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Olivier Ronveaux @ MRF's Meningitis & Septicaemia in Children & Adults 2015Dr Olivier Ronveaux @ MRF's Meningitis & Septicaemia in Children & Adults 2015
Dr Olivier Ronveaux @ MRF's Meningitis & Septicaemia in Children & Adults 2015
 
The meaning of meningococcal carriage - Slideset by Professor Adam Finn
The meaning of meningococcal carriage - Slideset by Professor Adam FinnThe meaning of meningococcal carriage - Slideset by Professor Adam Finn
The meaning of meningococcal carriage - Slideset by Professor Adam Finn
 
Debate on aggressive vs restricted fluid resuscitation in childhood sepsis
Debate on aggressive vs restricted fluid resuscitation in childhood sepsisDebate on aggressive vs restricted fluid resuscitation in childhood sepsis
Debate on aggressive vs restricted fluid resuscitation in childhood sepsis
 
Round up of new developments in clinical management of meningitis or sepsis i...
Round up of new developments in clinical management of meningitis or sepsis i...Round up of new developments in clinical management of meningitis or sepsis i...
Round up of new developments in clinical management of meningitis or sepsis i...
 
Neonatal meningitis in the UK
Neonatal meningitis in the UKNeonatal meningitis in the UK
Neonatal meningitis in the UK
 
Moraxella
MoraxellaMoraxella
Moraxella
 
Moraxella catarrhalis
Moraxella catarrhalisMoraxella catarrhalis
Moraxella catarrhalis
 
Salmonella infections
Salmonella infectionsSalmonella infections
Salmonella infections
 
Salmonellosis
Salmonellosis Salmonellosis
Salmonellosis
 
Neisseria meningitidis
Neisseria meningitidisNeisseria meningitidis
Neisseria meningitidis
 

Similar to Professor Martin Maiden @ MRF's Meningitis & Septicaemia in Children & Adults 2015

Population genomics and public health
Population genomics and public healthPopulation genomics and public health
Population genomics and public health
Martin Maiden
 
Proof of concept of WGS based surveillance: meningococcal disease
Proof of concept of WGS based surveillance: meningococcal diseaseProof of concept of WGS based surveillance: meningococcal disease
Proof of concept of WGS based surveillance: meningococcal disease
European Centre for Disease Prevention and Control (ECDC)
 
Neisseria m.
Neisseria m. Neisseria m.
Neisseria m.
Sarina Kf
 
Pneumonia risk factors
Pneumonia risk factorsPneumonia risk factors
Pneumonia risk factors
Jordi Roig
 
Antibiotics in the management of chronic periodontitis.ppt
Antibiotics in the management of chronic periodontitis.pptAntibiotics in the management of chronic periodontitis.ppt
Antibiotics in the management of chronic periodontitis.ppt
malti19
 
TRICHOMONIASIS.pdf
TRICHOMONIASIS.pdfTRICHOMONIASIS.pdf
TRICHOMONIASIS.pdf
Qiestiena Aliya Faiezi
 
ВИЧ-инфекция, воспаление и метаболические нарушения-связь с сердечно-сосудист...
ВИЧ-инфекция, воспаление и метаболические нарушения-связь с сердечно-сосудист...ВИЧ-инфекция, воспаление и метаболические нарушения-связь с сердечно-сосудист...
ВИЧ-инфекция, воспаление и метаболические нарушения-связь с сердечно-сосудист...
hivlifeinfo
 
Prevalence and Antimicrobial Susceptibility of Methicillin Resistant Staph
Prevalence and Antimicrobial Susceptibility of Methicillin Resistant StaphPrevalence and Antimicrobial Susceptibility of Methicillin Resistant Staph
Prevalence and Antimicrobial Susceptibility of Methicillin Resistant StaphJoshua Owolabi
 
Polymicrobial colonisation of the nasopharynx in UK children
Polymicrobial colonisation of the nasopharynx in UK childrenPolymicrobial colonisation of the nasopharynx in UK children
Polymicrobial colonisation of the nasopharynx in UK children
Rebeccagladstone
 
antonioahncv2018
antonioahncv2018antonioahncv2018
antonioahncv2018
Antonio Ahn
 
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
NephroTube - Dr.Gawad
 
12879 2017 article_2595
12879 2017 article_259512879 2017 article_2595
12879 2017 article_2595
Julio A. Diaz M.
 
e00353-16.full
e00353-16.fulle00353-16.full
e00353-16.fullDavid King
 
Anaplasmosis granulocitica humana
Anaplasmosis granulocitica humanaAnaplasmosis granulocitica humana
Anaplasmosis granulocitica humana
Luisjo FY
 
Anaplasmosis granulocitica humana-AGH
Anaplasmosis granulocitica humana-AGHAnaplasmosis granulocitica humana-AGH
Anaplasmosis granulocitica humana-AGH
LUIS JOSE FERNANDEZ YEPEZ
 
single-cell-sequencing-research-review
single-cell-sequencing-research-reviewsingle-cell-sequencing-research-review
single-cell-sequencing-research-reviewSwati Kadam Ph.D.
 

Similar to Professor Martin Maiden @ MRF's Meningitis & Septicaemia in Children & Adults 2015 (20)

Population genomics and public health
Population genomics and public healthPopulation genomics and public health
Population genomics and public health
 
Proof of concept of WGS based surveillance: meningococcal disease
Proof of concept of WGS based surveillance: meningococcal diseaseProof of concept of WGS based surveillance: meningococcal disease
Proof of concept of WGS based surveillance: meningococcal disease
 
Neisseria m.
Neisseria m. Neisseria m.
Neisseria m.
 
Pneumonia risk factors
Pneumonia risk factorsPneumonia risk factors
Pneumonia risk factors
 
Antibiotics in the management of chronic periodontitis.ppt
Antibiotics in the management of chronic periodontitis.pptAntibiotics in the management of chronic periodontitis.ppt
Antibiotics in the management of chronic periodontitis.ppt
 
ACC Cancer Cell May 2016
ACC Cancer Cell May 2016ACC Cancer Cell May 2016
ACC Cancer Cell May 2016
 
CV
CVCV
CV
 
TRICHOMONIASIS.pdf
TRICHOMONIASIS.pdfTRICHOMONIASIS.pdf
TRICHOMONIASIS.pdf
 
ISPPD_2016_POSTER_413 copy
ISPPD_2016_POSTER_413 copyISPPD_2016_POSTER_413 copy
ISPPD_2016_POSTER_413 copy
 
ВИЧ-инфекция, воспаление и метаболические нарушения-связь с сердечно-сосудист...
ВИЧ-инфекция, воспаление и метаболические нарушения-связь с сердечно-сосудист...ВИЧ-инфекция, воспаление и метаболические нарушения-связь с сердечно-сосудист...
ВИЧ-инфекция, воспаление и метаболические нарушения-связь с сердечно-сосудист...
 
Prevalence and Antimicrobial Susceptibility of Methicillin Resistant Staph
Prevalence and Antimicrobial Susceptibility of Methicillin Resistant StaphPrevalence and Antimicrobial Susceptibility of Methicillin Resistant Staph
Prevalence and Antimicrobial Susceptibility of Methicillin Resistant Staph
 
Polymicrobial colonisation of the nasopharynx in UK children
Polymicrobial colonisation of the nasopharynx in UK childrenPolymicrobial colonisation of the nasopharynx in UK children
Polymicrobial colonisation of the nasopharynx in UK children
 
PUBLICATIONS
PUBLICATIONSPUBLICATIONS
PUBLICATIONS
 
antonioahncv2018
antonioahncv2018antonioahncv2018
antonioahncv2018
 
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
Membranoproliferative GN - Road to Diagnosis & Management - What is the evide...
 
12879 2017 article_2595
12879 2017 article_259512879 2017 article_2595
12879 2017 article_2595
 
e00353-16.full
e00353-16.fulle00353-16.full
e00353-16.full
 
Anaplasmosis granulocitica humana
Anaplasmosis granulocitica humanaAnaplasmosis granulocitica humana
Anaplasmosis granulocitica humana
 
Anaplasmosis granulocitica humana-AGH
Anaplasmosis granulocitica humana-AGHAnaplasmosis granulocitica humana-AGH
Anaplasmosis granulocitica humana-AGH
 
single-cell-sequencing-research-review
single-cell-sequencing-research-reviewsingle-cell-sequencing-research-review
single-cell-sequencing-research-review
 

More from Meningitis Research Foundation

Prof Rob Heyderman
Prof Rob HeydermanProf Rob Heyderman
Prof Rob Heyderman
Meningitis Research Foundation
 
Marco safadi
Marco safadiMarco safadi
Brenda kwambana adams
Brenda kwambana adamsBrenda kwambana adams
Brenda kwambana adams
Meningitis Research Foundation
 
Professor Muhamed-Kheir Taha
Professor Muhamed-Kheir TahaProfessor Muhamed-Kheir Taha
Professor Muhamed-Kheir Taha
Meningitis Research Foundation
 
Potential use of MenABCWY vaccines
Potential use of MenABCWY vaccinesPotential use of MenABCWY vaccines
Potential use of MenABCWY vaccines
Meningitis Research Foundation
 
Dr william hanage
Dr william hanageDr william hanage
Dr Maria Deloria Knoll
Dr Maria Deloria KnollDr Maria Deloria Knoll
Dr Maria Deloria Knoll
Meningitis Research Foundation
 
Professor Nelesh govender
Professor Nelesh govender Professor Nelesh govender
Professor Nelesh govender
Meningitis Research Foundation
 
Professor Sir Andrew Pollard
Professor Sir Andrew PollardProfessor Sir Andrew Pollard
Professor Sir Andrew Pollard
Meningitis Research Foundation
 
Dr Manuel krone
Dr Manuel kroneDr Manuel krone
Yangyupei yang
Yangyupei yangYangyupei yang
Dr Rodolfo villena
Dr Rodolfo villena  Dr Rodolfo villena
Dr Rodolfo villena
Meningitis Research Foundation
 
Sara katz
Sara katzSara katz
Dr Xin wang
Dr Xin wangDr Xin wang
Professor Cal MacLennan
Professor Cal MacLennanProfessor Cal MacLennan
Professor Cal MacLennan
Meningitis Research Foundation
 
Dr Sami gottlieb
Dr Sami gottliebDr Sami gottlieb
Dr Lee hampton
Dr Lee hamptonDr Lee hampton
Professor Stefan flasche
Professor Stefan flascheProfessor Stefan flasche
Professor Stefan flasche
Meningitis Research Foundation
 
Professor Shrijana shrestha
Professor Shrijana shresthaProfessor Shrijana shrestha
Professor Shrijana shrestha
Meningitis Research Foundation
 
Professor David goldblatt
Professor David goldblattProfessor David goldblatt
Professor David goldblatt
Meningitis Research Foundation
 

More from Meningitis Research Foundation (20)

Prof Rob Heyderman
Prof Rob HeydermanProf Rob Heyderman
Prof Rob Heyderman
 
Marco safadi
Marco safadiMarco safadi
Marco safadi
 
Brenda kwambana adams
Brenda kwambana adamsBrenda kwambana adams
Brenda kwambana adams
 
Professor Muhamed-Kheir Taha
Professor Muhamed-Kheir TahaProfessor Muhamed-Kheir Taha
Professor Muhamed-Kheir Taha
 
Potential use of MenABCWY vaccines
Potential use of MenABCWY vaccinesPotential use of MenABCWY vaccines
Potential use of MenABCWY vaccines
 
Dr william hanage
Dr william hanageDr william hanage
Dr william hanage
 
Dr Maria Deloria Knoll
Dr Maria Deloria KnollDr Maria Deloria Knoll
Dr Maria Deloria Knoll
 
Professor Nelesh govender
Professor Nelesh govender Professor Nelesh govender
Professor Nelesh govender
 
Professor Sir Andrew Pollard
Professor Sir Andrew PollardProfessor Sir Andrew Pollard
Professor Sir Andrew Pollard
 
Dr Manuel krone
Dr Manuel kroneDr Manuel krone
Dr Manuel krone
 
Yangyupei yang
Yangyupei yangYangyupei yang
Yangyupei yang
 
Dr Rodolfo villena
Dr Rodolfo villena  Dr Rodolfo villena
Dr Rodolfo villena
 
Sara katz
Sara katzSara katz
Sara katz
 
Dr Xin wang
Dr Xin wangDr Xin wang
Dr Xin wang
 
Professor Cal MacLennan
Professor Cal MacLennanProfessor Cal MacLennan
Professor Cal MacLennan
 
Dr Sami gottlieb
Dr Sami gottliebDr Sami gottlieb
Dr Sami gottlieb
 
Dr Lee hampton
Dr Lee hamptonDr Lee hampton
Dr Lee hampton
 
Professor Stefan flasche
Professor Stefan flascheProfessor Stefan flasche
Professor Stefan flasche
 
Professor Shrijana shrestha
Professor Shrijana shresthaProfessor Shrijana shrestha
Professor Shrijana shrestha
 
Professor David goldblatt
Professor David goldblattProfessor David goldblatt
Professor David goldblatt
 

Recently uploaded

Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Yodley Lifesciences
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 

Recently uploaded (20)

Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley LifesciencesPharma Pcd Franchise in Jharkhand - Yodley Lifesciences
Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 

Professor Martin Maiden @ MRF's Meningitis & Septicaemia in Children & Adults 2015

  • 1. ! ! UKMenCar4: carriage studies, high-resolution genomics, and disease control Martin Maiden, UKMenCar4 Consortium
  • 2. Meningococcal structure and characterisation Jolley, K. A., Brehony, C. & Maiden, M. C. (2007). Molecular typing of meningococci: recommendations for target choice and nomenclature. FEMS Microbiol Rev 31, 89-96. Component Phenotypic Genotypic Capsule Serogroup cps region OMPS Serotype, Subtype, etc. porA, porB, fetA, etc. Housekeeping genes MLEE MLST Ribosomes MALDITOF 16s rRNA, rMLST Neisseria meningitidis B: P1.7,16: F3-3: ST-32 (cc32)
  • 3. Meningococcal disease, England & Wales: the long view - 5.00 10.00 15.00 20.00 25.00 30.00 35.00 Incidencerate/100,000 Year The Big Questions: (i) Why was there such high disease incidence mid-1980s – mid-2000s?; (ii) Why has it reduced?; and, (iii) What is likely to happen next? Cerebrospinal Fever Meningococcal: infection meningitis & septicaemia Data: courtesy Mary Ramsay Shamaz Ladhani, Public Health England
  • 4. Meningococcal disease epidemics England & Wales 1984-2013 Data: Meningococcal Reference Unit, Public Health England 1982-1990 Stonehouse Outbreak Group B 1993-1999 Group C Outbreaks 2001 - Group B Incidence declines Late 1999 Group C Conjugate Meningococcal (MCC) Vaccines introduced
  • 5. Meningitis Research Foundation Meningococcus Genome Library • Charity funded. • Open access. • All available England and Wales, Scotland (and Ireland, WT funded) meningococcal isolates. • Assembled & annotated contiguous sequence data. http://www.meningitis.org/current-projects/genome
  • 6. Diversity of disease causing meningococci MRF-MGL isolates 2010-2012 Hill, D.M.C., Lucidarme, J., Gray S.J., Newbold , L.S., Ure, R., Brehony, C., Harrison, O.B., Bray, J.E., Jolley, K.A., Bratcher H.B.,, Parkhill, J., Tang, C.M., Borrow, R., and Maiden, M.C.J. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study. Lancet Infectious diseases, DOI: http://dx.doi.org/10.1016/S1473-3099(15)00267-4 • A total of 923 isolates from England, Wales and Northern Ireland. • 899 from England and Wales: • Scanned at >2000 loci; • 2-313 alleles/locus; • 219 STs, 22 clonal complexes; • 496 rSTs (ribosomal sequence types); • Most isolates (78%) belonged to 6 clonal complexes.
  • 7. 0 500 1000 1500 2000 2500 3000 1975 ~ 1985 ~ 1995 ~ 1999 2000 2001 ~ 2005 2006 2007 2008 2009 2010 2011 2012 41/44 269 11 32 8 213 23 167 174 22 Other UA NT Epidemics are dominated by particular meningococci Hill, D.M.C., Lucidarme, J., Gray S.J., Newbold , L.S., Ure, R., Brehony, C., Harrison, O.B., Bray, J.E., Jolley, K.A., Bratcher H.B.,, Parkhill, J., Tang, C.M., Borrow, R., and Maiden, M.C.J. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study. Lancet Infectious diseases, DOI: http://dx.doi.org/10.1016/S1473-3099(15)00267-4
  • 8. Age association of meningococcal genotypes (MRF-MGL 2010-2012) 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% <1 1-4 5-9 10-14 15-19 20-24 25-29 30-39 40-49 50-69 >70 Proportionofcases Age category Minor clonal complexes ND ST-174 complex ST-461 complex ST-162 complex ST-22 complex ST-23 complex/Cluster A3 ST-213 complex ST-60 complex ST-41/44 complex/Lineage 3 ST-269 complex ST-32 complex/ET-5 complex ST-11 complex/ET-37 complex Hill, D.M.C., Lucidarme, J., Gray S.J., Newbold , L.S., Ure, R., Brehony, C., Harrison, O.B., Bray, J.E., Jolley, K.A., Bratcher H.B.,, Parkhill, J., Tang, C.M., Borrow, R., and Maiden, M.C.J. Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study. Lancet Infectious diseases, DOI: http://dx.doi.org/10.1016/S1473-3099(15)00267-4
  • 10. Meningococcal carriage by age Christensen, H., May, M., Bowen, L., Hickman, M. & Trotter, C. L. (2010). Meningococcal carriage by age: a systematic review and meta-analysis. The Lancet Infectious Diseases 10, 853-861.
  • 11. 100 years of disease and carriage studies Glover, J. A. (1918). "Spacing out" in the Prevention of Military Epidemics of Cerebro-Spinal Fever. Br Med J 2, 509-512. Glover, J. A. (1918). Observations on the Meningococcus Carrier- Rate in relation to density of population in Sleeping Quarters. J Hyg (Lond) 17, 367-379. Glover, J. A. (1918). The Cerebro- Spinal Fever Epidemic of 1917 at X Depot. J Hyg (Lond) 17, 350-365.
  • 12. Meningococcal disease England & Wales Data: Meningococcal Reference Unit, Public Health England Late 1999 Group C Conjugate Meningococcal (MCC) Vaccines introduced
  • 13. UK Meningococcal carriage study: UKMenCar1-3, 1999-2001 Ibarz-Pavon, A. B., et al. (2011). Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation. J Infect Dis 204, 1046-1053. Maiden, M. C., et al. (2008). Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity. J Infect Dis 197, 737-743. Maiden, M. C., Stuart, J. M. & Group, U. M. C. (2002). Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 359, 1829-1831. Glasgow Stockport Nottingham Oxford London Plymouth Wales MRU/SMPRL Phenotype 16,700 X 3 Sequence type siaD/cnl Questionnaire Risk factors for carriage 2,500 X 3
  • 14. UKMenCar 1-3: 8,000 carried meningococci, a diverse population 0 2 4 6 8 10 12 14 16 1999 2000 2001 Proportionofmeningococci(%) Year ST-11 complex ST-865 complex ST-8 complex ST-254 complex ST-212 complex ST-162 complex ST-92 complex ST-18 complex ST-178 complex ST-1136 complex ST-750 complex ST-41/44 complex ST-167 complex ST-32 complex ST-60 complex ST-282 complex ST-364 complex ST-35 complex ST-22 complex ST-198 complex ST-103 complex ST-23 complex ST-53 complex ST-1157 complex ST-269 complex ST-1117 complex ST-213 complex ST-461 complex ST-174 complex ST-106 complex ST-116 complex ST-334 complex ST-37 complex ST-376 complex Ibarz-Pavon, A. B., Maclennan, J., Andrews, N. J., Urwin, R., Gray, S. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., Ala'aldeen, D. A., Crook, D. W., Cann, K., Harrison, S., Cunningham, R., Baxter, D., Kaczmarski, E., Cameron, J. C. & Stuart, J. M., & Maiden, M. C. (In press). Changes in serogroup and genotype prevalence among carried meningococci in the United Kingdom during vaccine implementation. J Infect Dis.
  • 15. UKMenCar1-3: major disease associated lineages 0 2 4 6 8 10 12 14 16 1999 2000 2001 Proportionofmeningococci(%) Year ST-11 complex ST-8 complex ST-41/44 complex ST-32 complex ST-269 complex Clonal complex 1998/9 n 1998/9 % 2000/1 n 2000/1 % ST-11 complex 553 32.8 264 20.5 ST-41/44 complex 423 25.1 373 28.9 ST-269 complex 253 15.0 275 21.3 ST-32 complex 99 5.9 79 6.1 ST-8 complex 84 5.0 15 1.2 a) Carried meningococcal clonal complexes b) Clonal complexes isolated from disease Maiden, M. C., Ibarz-Pavon, A. B., Urwin, R., Gray, S. J., Andrews, N. J., Clarke, S. C., Walker, A. M., Evans, M. R., Kroll, J. S., Neal, K. R., Ala'aldeen, D. A., Crook, D. W., Cann, K., Harrison, S., Cunningham, R., Baxter, D., Kaczmarski, E., Maclennan, J., Cameron, J. C. & Stuart, J. M. (2008). Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity. J Infect Dis 197, 737-743.
  • 16. UKMenCar 1-3: Carriage of ST-11 genogroup C isolates 0 0.05 0.1 0.15 0.2 0.25 0.3 0.35 1999 2000 2001 %Carriage Year NG C Maiden, M. C., et al. (2008). Impact of Meningococcal Serogroup C Conjugate Vaccines on Carriage and Herd Immunity. J Infect Dis 197, 737-743.
  • 17. Clonal complex, disease, and serogroup England and Wales, 1999 Clonal complex Disease association OR B C W-135 Y ST-8 14.7 [6.8 - 31.9] 11 69 0 0 ST-11 28.7 [20.1 - 41.1] 7 525 1 0 ST-22 0.23 [0.17 - 0.32] 5 0 42 1 ST-23 0.14 [0.07 - 0.28] 0 1 0 9 ST-32 2.1 [1.5 - 3.0] 80 1 0 0 ST-35 0.29 [0.16 - 0.53] 13 0 0 0 ST-41/44 1.8 [1.5 - 2.1] 390 7 0 0 ST-213 0.4 [0.28 - 0.57] 39 1 0 0 ST-269 4.4 [3.4 - 5.8] 214 7 0 0 Unassigned 0.28 [0.24 - 0.34] 140 32 2 9 Data: Ure R., Gray S., McCarthy N.D., Pavon A.B., and Maiden, M.C. Unpublished.
  • 18. Risk factors for carriage Smoking Kissing Y Y Y N N Y N N MacLennan, J., Kafatos, G., Neal, K., Andrews, N., Cameron, J. C., Roberts, R., Evans, M. R., Cann, K., Baxter, D. N., Maiden, M. C. & Stuart, J. M. (2006). Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis 12, 950-957.
  • 19. The long-term impact of herd immunity Trotter, C. L. & Maiden, M. C. (2009). Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Review Vaccines 8, 851-861.
  • 20. Meningococcal disease England & Wales Data: Meningococcal Reference Unit, Public Health England 1982-1990 Stonehouse Outbreak Group B 1993-1999 Group C Outbreaks 2001 - Group B Incidence Declines Late 1999 Group C Conjugate Meningococcal (MCC) Vaccine introduced
  • 21. UKMenCar4: Initial aims 1) Compare the genotypes of meningococcal disease and carriage isolates in high and low incidence settings (UK 1999 and UK 2014). 2) Investigate the risk factors for meningococcal carriage and in particular the effect of changes in social behaviour with respect to smoking, kissing, and socialising. Incidence Carriage Disease High (1999) ✔ ✔ Low (2014) ✔ ✔
  • 22. UK Meningococcal carriage study, UKMenCar4: 2014-5 Glasgow Stockport Manchester Oxford London Plymouth Cardiff MaidstoneBristol Wigan Preston • Multi-centre cross-sectional survey of meningococcal carriage • 18,000 UK teenagers • Compared to UKmenCAR1-3: – Similar study sites; – Same age group; – Sampling in schools/colleges; – Similar time of year (but extended from autumn to spring); – Similar microbiological methods; – Same key risk factors.
  • 24. Tributyrin Test * Positive reaction: yellow/yellow orange * Negative reaction: red Results: Moraxella catarrhalis (+) Neisseria spp. (-) Microbiology testing
  • 25. Genome sequencing of Neisseria meningitidis isolates ||||||||||| OX40001 ||||||||||| OX40001 ||||||||||| OX40001 Sequence read processing Visualization
  • 26. Analysis of study data These are just some of the types of analyses possible …
  • 27. Cluster 1 Cluster 2 Cluster 3 Genome analysis of disease and carriage isolates from Chad  Reference genome: 2070 genes from ST5 WUE2594 [Schoen, C. et al., 2011]  Genome comparator output:  1542 genes identical in all genomes (1347 share same allele as ref/196 have a different allele);  66 genes missing in all 23 genomes;  221 incomplete genes were excluded;  242 variable genes. Diallo K, Trotter C, Borrow R, Stuart JM, Greenwood BM, Maiden MCJ, & MenAfriCar consortium. Unpublished.
  • 28. UKMenCar4 totals by centre Centre Recruitment target Final total Glasgow 2600 2632 Bristol 2600 1814 London 2600 1933 Oxford 2600 2141 Stockport 2600 2438 Cardiff 2600 3130 Plymouth 1500 2252 Maidstone 1000 1022 Preston 1000 1016 Central Manchester & Wigan 1000 3497 Total 20,100 21,874
  • 29. UKMenCar4: Meningococcal carriage rates 1999-2000 2000-2001 2001-2002 2014-2015 Carriage of Neisseria meningitidis * Putative meningococci Stockport 25.4 % 24.9 % 24.4 % 11.7 % Cardiff 14.4 % 17.6 % 16.7 % 8.6 % Glasgow 11.7 % 16.2 % 17.5 % 7.1 % Oxford 25.2 % 22.6 % 20.3 % 9.3 % Plymouth 8.2 % 15.4 % 19.9 % 5.9 % Bristol N/A N/A N/A 8.4 % North Thames 9.1 % 12.5 % 14.4 % N/A Bangor 20.9 % 19.2 % 22.9 % N/A Nottingham 19.9 % 19.8 % 16.0 % N/A
  • 30. Shisha smokingSmoking ban 2006/7 Changes since UKMencar1-3: smoking
  • 31. Meningococcal disease England & Wales Data: Meningococcal Reference Unit, Public Health England 1982-1990 Stonehouse Outbreak Group B 1993-1999 Group C Outbreaks 2001 - Group B Incidence declines Late 1999 Group C Conjugate Meningococcal (MCC) Vaccine introduced What Next?
  • 32. MRF Genome Library Era: England and Wales 2010-2015 0 50 100 150 200 250 300 350 400 450 B C W Y http://www.meningitis.org/current-projects/genome
  • 33. Lineage 11 (cc11) Group W: UK epidemiology Current UK UK Hajj UK 1996 (n=3) 1997 (n=2) 1998 (n=2) UK 1975 (n=6) 1987 (n=1) 1989 (n=1) 1990 (n=1) UK 1996 (n=2) 1998 (n=1) Argentina 2008-2012 Brazil 2008-2011 Current South Africa Lucidarme, J., Hill, D. M., Bratcher, H. B., Gray, S. J., du Plessis, M., Tsang, R. S., Vazquez, J. A., Taha, M. K., Ceyhan, M., Efron, A. M., Gorla, M. C., Findlow, J., Jolley, K. A., Maiden, M. C. & Borrow, R. (2015). Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage. J Infect In the press. 0 10 20 30 40 50 60 70 80 90 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 NumberofCases Year N. meningitidis cases per year among inpatients in Bamako, Mali (2002-2012) Group A meningococcal cases Group W135 meningococcal cases Nm W England and Wales
  • 35. UKMenCar5: Evaluation of changes in the UK national meningococcal immunisation programme UKMenCar4 provides the pre-vaccination baseline for circulating meningococci and will allow full evaluation of the impact of ACWY vaccine on meningococcal populations. 2014 2015 2016 2017 2018 UKMenCar4 ACWY vaccination UKMenCar5 with catch up

Editor's Notes

  1. This is shown in this slide of the odds ratio of carriage using a baseline of the youngest participants who were 15 years o age. The odds of carriage increases more than two fold between 15 and 19 years of age. The graph on the right shows how the carriage prevalence changes according to specific risk factors, namely smoking, kissing and attendance at pubs and clubs. The x axis shows how carriage of meningococci increases as attendance at pubs and clubs in the previous week increases in the absence of other risk factors. If you add in other risk factors of smoking and intimite kissing, the carriage rates increase such that these ones, the party animals, who are smoking, kissing and found out on the town most nights, have rates of carriage four times higher than these ones, the party poopers who don’t have any of these risk factors. And once you adjust for these risk factors, you can see that age no longer has an effect. And so it is not age per se that is responsible for the observed increase in meningococcal carriage, but their behaviour.
  2. Oxidase Test: Positive for the enzyme cytochrome c oxidase (a large transmembrane protein complex found in bacteria - It is the last enzyme in the respiratory electron transport chain of the bacterial membrane. Grams Stain: Gm(-) diplococci Tributyrin Test: hydrolysis enzyme
  3. Second generation sequencing does not produce ‘trace files’ like Sanger sequencing, electronic reads are processed directly using Velvet (algorithm based de novo genomic assembler) Additional programs are needed if the sequence files need to be viewed – something like Bowtie (an ultrafast memory-efficient short read aligner from Johns Hopkins Univ.) + Tablet (high-performance graphical viewer from The James Hutton Inst.)
  4. Antigen distribution (pie charts from Ellie’s paper) Comparison to disease in the UK (graph from Dot’s paper)
  5. Full characterisation of isolates has not yet been undertaken, and these are the rates of putative meningococci that hae been identified to the level of oxidase positive, gram negative meningococci, and we know we will find some commensals and some moraxella amongst them. Despite this, I think it is clear that the overall carriage rates have dropped by at least 50%. Consistently seen across the centres. Previously carriage rates were around 17-18%, now they are more like 8% and bearing in mind these are putative meningoccocci these rates are likely to drop.
  6. We were particularly interested in changes in smoking habits over the past 15 years, most notably the smoking ban in 2006 in Scotland and 2007 in the UK would have on meningococcal carriage, possibly counteracted in part by an increase in shisha smoking which was almost non-existent fifteen years ago amongst teenagers and becoming more popular now. There are few data available on how much teenagers are currently shisha, and we thought that potentially it provided a warm moist environment in the presence of tobacco smoke and a shared mouthpiece which might facilitate transmission of meningococci.